ArticleExperimental dermatology2009

Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.

Jürgen Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.